P01-DK-55546/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	2
2003	2
2004	4
2005	3
2006	4
2007	2
2010	1
2011	2
2013	1
2014	2
2024	0

1

Management of glomerular proteinuria: a commentary.

Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA. Wilmer WA, et al. J Am Soc Nephrol. 2003 Dec;14(12):3217-32. doi: 10.1097/01.asn.0000100145.27188.33. J Am Soc Nephrol. 2003. PMID: 14638920 Review.

2

Timed urine collections are not needed to measure urine protein excretion in clinical practice.

Shidham G, Hebert LA. Shidham G, et al. Am J Kidney Dis. 2006 Jan;47(1):8-14. doi: 10.1053/j.ajkd.2005.10.013. Am J Kidney Dis. 2006. PMID: 16377380 Review. No abstract available.

3

Mycophenolate therapy of SLE membranous nephropathy.

Spetie DN, Tang Y, Rovin BH, Nadasdy T, Nadasdy G, Pesavento TE, Hebert LA. Spetie DN, et al. Kidney Int. 2004 Dec;66(6):2411-5. doi: 10.1111/j.1523-1755.2004.66030.x. Kidney Int. 2004. PMID: 15569333 Free article. Clinical Trial.

4

Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Rovin BH, et al. J Am Soc Nephrol. 2005 Feb;16(2):467-73. doi: 10.1681/ASN.2004080658. Epub 2004 Dec 15. J Am Soc Nephrol. 2005. PMID: 15601744

5

An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A.

Jaatinen T, Chung EK, Ruuskanen O, Lokki ML. Jaatinen T, et al. Hum Immunol. 2002 Aug;63(8):683-9. doi: 10.1016/s0198-8859(02)00416-0. Hum Immunol. 2002. PMID: 12121677

6

Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.

Parikh SV, Nagaraja HN, Hebert L, Rovin BH. Parikh SV, et al. Clin J Am Soc Nephrol. 2014 Feb;9(2):279-84. doi: 10.2215/CJN.05040513. Epub 2013 Nov 21. Clin J Am Soc Nephrol. 2014. PMID: 24262502 Free PMC article.

7

Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.

Pesavento TE, Bay WH, Agarwal G, Hernandez RA Jr, Hebert LA. Pesavento TE, et al. Am J Kidney Dis. 2004 Mar;43(3):e3-6. doi: 10.1053/j.ajkd.2003.11.015. Am J Kidney Dis. 2004. PMID: 14981634

8

Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.

Birmingham DJ, Gavit KF, McCarty SM, Yu CY, Rovin BH, Nagaraja HN, Hebert LA. Birmingham DJ, et al. Clin Exp Immunol. 2006 Feb;143(2):274-80. doi: 10.1111/j.1365-2249.2005.02983.x. Clin Exp Immunol. 2006. PMID: 16412051 Free PMC article.

9

Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.

Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Rice R, Birmingham DJ, Yu CY, Spetie DN, Aziz A, Hebert LA. Rovin BH, et al. Kidney Int. 2005 Aug;68(2):747-59. doi: 10.1111/j.1523-1755.2005.00453.x. Kidney Int. 2005. PMID: 16014052 Free article. Clinical Trial.

10

An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy.

Kabir A, Nadasdy T, Nadasdy G, Hebert LA. Kabir A, et al. Am J Kidney Dis. 2004 Apr;43(4):757-60. doi: 10.1053/j.ajkd.2003.08.050. Am J Kidney Dis. 2004. PMID: 15042555 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year